[
    [
        {
            "time": "2021-08-18",
            "original_text": "人福医药子公司一款治疗抑郁症药物获批。晚间重要公告2021年8月18日星期三。人福医药：盐酸安非他酮缓释片获得药品注册证书。",
            "features": {
                "keywords": [
                    "人福医药",
                    "抑郁症药物",
                    "盐酸安非他酮缓释片",
                    "药品注册证书"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "人福医药子公司一款治疗抑郁症药物获批。晚间重要公告2021年8月18日星期三。人福医药：盐酸安非他酮缓释片获得药品注册证书。",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]